# FDA 483 - Integrated Commercialization Solutions LLC - May 15, 2025

Source: https://www.keypedia.com/records/483/integrated-commercialization-solutions-llc/01e17eba-47bc-48a8-a381-715fa6258a17

> FDA 483 for Integrated Commercialization Solutions LLC on May 15, 2025. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Integrated Commercialization Solutions LLC
- Inspection Date: 2025-05-15
- Product Type: drugs
- Office Name: Cincinnati District Office
- Summary: Integrated Commercialization Solutions LLC, a drug labeler in Lockbourne, OH, was cited for failing to adequately sample and examine labeling and packaging materials upon receipt and before use. The inspection revealed deficiencies in their procedures and documentation for quality checks on labels, leading to the use of uninspected labels in drug product packaging. This indicates a significant lapse in quality control for critical drug product components.

## Related Officers

- [Ucheabuchi C. Chudi-nwankwor](https://www.keypedia.com/people/ucheabuchi-c-chudi-nwankwor/18b01d08-3cfd-4ace-97b2-5f54b6427661)

Company: https://www.keypedia.com/companies/integrated-commercialization-solutions-llc/d1ff0552-0b6b-4a8d-bbf0-8725d6b0641c

Office: https://www.keypedia.com/offices/cincinnati-district-office/b67a0c35-82e3-4176-9039-988378f65c22